查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040705

美國不孕症診斷市場規模、佔有率和趨勢分析報告：按手術類型、技術類型、臨床環境、地區和細分市場預測（2026-2033 年）

U.S. Fertility Diagnostic Market Size, Share & Trends Analysis Report By Procedure Type (X-ray-Based Tubal Patency Testing, Structural & Morphologic Imaging), By Technology Type, By Clinical Setting, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

美國不孕症診斷市場概述

2025 年美國生育診斷市場價值為 10.7 億美元，預計到 2033 年將達到 19.2 億美元，2026 年至 2033 年的複合年成長率為 7.6%。

不孕症盛行率不斷上升以及可識別病因比例較高，是美國不孕症診斷市場的主要促進因素。

此外，對全面診斷評估的日益重視正在推動不孕症診斷解決方案的持續成長和技術進步。以下章節概述了關鍵市場促進因素，包括研發和影響不孕症診斷市場的趨勢。這反映了技術進步、人口結構變化以及其他有助於提升診斷能力、改善不孕症早期檢測以及提高美國先進不孕症檢測解決方案可及性的因素。

目錄

第1章：本報告的範圍與調查方法

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場動態
  • 不孕症診斷產品：法律規範和當前保險報銷狀況
  • 科技情勢
  • 產業分析工具

第4章：美國不孕症診斷市場分析

  • 美國不孕症診斷市場，2021-2033年
  • 2025年美國不孕症盛行率和發生率（按性別分類）
  • 不孕症盛行率和發生率對不孕症診斷檢測需求的影響。

第5章：美國不孕症診斷市場：TAM、SAM 與 SOM 分析

  • 2021-2033年總潛在市場（TAM）分析
  • 2021-2033年適用目標市場（SAM）分析
  • 可用收購市場（SOM）分析，2021-2033年

第6章：美國不孕症診斷市場：依手術類型分類的估算與趨勢分析

  • 按手術類型分類的波動分析、市場佔有率分析（2025 年和 2033 年）
  • 美國不孕症診斷市場：按手術類型分類的估計和預測，2021-2033年
    • 輸卵管通暢性的X光檢查
    • 超音波輸卵管通暢性檢查
    • 專有造影劑控制系統
    • 結構和形態成像診斷
    • 其他

第7章：美國不孕症診斷市場：依技術類型分類的估算與趨勢分析

  • 基於技術類型的波動分析、市場佔有率分析（2025 年和 2033 年）
  • 美國不孕症診斷市場：按技術類型分類的估計和預測 / 2021-2033年
    • 基於X光的技術
    • 超音波技術
    • 專有診斷設備

第8章：美國不孕症診斷市場：依臨床環境分類的估算與趨勢分析

  • 依臨床環境和市佔率分析波動（2025 年和 2033 年）
  • 美國不孕症診斷市場估計與預測：依臨床環境分類，2021-2033年
    • 不孕症及生殖醫學診所
    • 婦科/女性健康診所
    • 放射科和診斷影像中心
    • 門診醫院
    • 其他

第9章：美國不孕症診斷市場：區域估算與趨勢分析

  • 美國不孕症診斷市場：區域波動分析
  • 區域波動分析、市佔率分析（2025 年及 2033 年）
  • 美國不孕症診斷市場：區域估計與預測
  • 西方
  • 東南
  • 西南
  • 中西部
  • 東北

第10章：美國不孕症診斷市場：競爭格局

  • Participants'Overview
  • 財務業績
  • 產品基準測試
    • Gedeon Richter
    • Femvue (Femasys Inc.)
    • Thomas Medical (MedGyn)
    • Koninklijke Philips NV
    • Ge Healthcare
    • Samsung Healthcare
    • Cooper Surgical, Inc.
    • Mindray Ds Usa, Inc.
    • Vio Healthtech Inc
    • Fujifilm Sonosite, Inc.
    • Olympus
    • Canon Medical Systems
    • Stryker
  • 參與企業
  • 2025年公司市場分析
  • 按手術技術分類的企業市場占有率分析（2025 年）
  • 策略規劃
    • 新產品發布
    • 併購
    • 夥伴關係與合作
    • 市場擴張
    • 產品核可
Product Code: GVR-4-68040-887-2

U.S. Fertility Diagnostic Market Summary

The U.S. fertility diagnostic market size was valued at USD 1.07 billion in 2025 and is projected to reach USD 1.92 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The rise in infertility and high rate of identifiable causes are key factors driving the U.S. market for fertility diagnostics.

In addition, the increasing emphasis on comprehensive diagnostic evaluations is supporting the continued growth and technological advancement of fertility diagnostic solutions. The section below outlines key market factors such as research and development and trends shaping the fertility diagnostic market. It reflects technological advancements, the impact of demographics, and other factors that are strengthening diagnostic capabilities, improving early infertility detection, and expanding access to advanced fertility testing solutions across the U.S.

U.S. Fertility Diagnostic Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. fertility diagnostic market report based on procedure type, technology, clinical setting, and region.

  • Procedure Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • X-ray-Based Tubal Patency Testing
  • Ultrasound-Based Tubal Patency Testing
    • HyCoSy (Hysterosalpingo-Contrast Sonography)
    • HyFoSy (Hysterosalpingo-Foam Sonography)
    • Others
  • Proprietary Controlled Contrast Systems Subdermal Implants
  • Structural & Morphologic Imaging
  • Others
  • Technology Outlook (Revenue, USD Billion, 2021 - 2033)
  • X-Ray-Based Technologies
  • Ultrasound-Based Technologies
  • Proprietary Diagnostic Devices
  • Clinical Setting Outlook (Revenue, USD Billion, 2021 - 2033)
  • Fertility & Reproductive Medicine Clinics
  • Gynecology / Women's Health Practices
  • Radiology & Imaging Centers
  • Hospital Outpatient Departments
  • Others
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • West
  • Southwest
  • Southeast
  • Midwest
  • Northeast

Table of Contents

Chapter 1 Report Scope & Research Methodology

  • 1.1 Market Segmentation
    • 1.1.1 Segment Definition
      • 1.1.1.1 Procedure Type
      • 1.1.1.2 Technology type
      • 1.1.1.3 Clinical setting
  • 1.2 Estimates and Forecast Timeline
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
    • 1.3.2 Purchased Database 16
    • 1.3.3 GVR's Internal Database
    • 1.3.4 Secondary Sources
    • 1.3.5 Primary Research
    • 1.3.6 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Three Pillars of Market Estimation
      • 1.6.1.1 Secondary market research
      • 1.6.1.2 Primary market intelligence
        • 1.6.1.2.1 In-depth interviews (IDIs)
        • 1.6.1.2.2 Online survey program
    • 1.6.2 Market Modeling & Forecasting
      • 1.6.2.1 Model 1: Procedure Type volume analysis
      • 1.6.2.2 Model 2: Technology adoption allocation
      • 1.6.2.3 Model 3: Device utilization modeling
      • 1.6.2.4 Model 4: Revenue estimation (Volume X Price)
      • 1.6.2.5 Top-down validation (Manufacturer revenue benchmarking)
      • 1.6.2.6 CAGR/forecasting calculations & assumptions
        • 1.6.2.6.1 Key forecasting drivers and weights
        • 1.6.2.6.2 Scenario framework (2026 - 2033)
        • 1.6.2.6.3 Factor-based impact assessment
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Research Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Procedure Type and Technology Type Snapshot
  • 2.3 Clinical Setting Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Delayed parenthood and changing demographics
        • 3.1.1.1.1 Case study published by the U.S. Census Bureau in January 2026: Reducing U.S. population growth and its implications for the fertility diagnostic market
      • 3.1.1.2 Rising prevalence of infertility
      • 3.1.1.3 Growth of assisted reproductive technologies (ART)
        • 3.1.1.3.1 Case study published in Gray Local Media Station in February 2026: Expansion of IVF clinics to meet rising ART demand in the U.S.
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 High costs and limited reimbursement
      • 3.1.2.2 Technological and data integration challenges
    • 3.1.3 Market Opportunity Analysis
      • 3.1.3.1 At home & point of care diagnostic solutions
      • 3.1.3.2 Expansion of male fertility diagnostics
    • 3.1.4 Market Challenge Analysis
      • 3.1.4.1 Regulatory complexity & approval delays
  • 3.2 Fertility Diagnostic Products: Regulatory Framework and Reimbursement Scenario
  • 3.3 Technology Landscape
    • 3.3.1 Case study published by the National Library of Medicine in March 2024: accuracy of Hystero-Salpingo-Foam Sonography (Hyfosy) for tubal patency testing
  • 3.4 Industry Analysis Tools
    • 3.4.1 Porter's Five Forces Analysis
    • 3.4.2 Pestle Analysis

Chapter 4 U.S. Infertility Market Analysis

  • 4.1 U.S. Infertility Market, 2021 - 2033 (USD Billion)
  • 4.2 Prevalence/Incidence of Infertility in the U.S., by Gender, 2025
  • 4.3 Impact of Infertility Prevalence/Incidence on Demand for Fertility Diagnostics
    • 4.3.1 Case study published by National Library of Medicine: impact of infertility prevalence on demand for fertility diagnostics
    • 4.3.2 Case study published by Raveco Medical in September 2025: importance of early infertility evaluation and its impact on fertility diagnostics demand

Chapter 5 U.S. Fertility Diagnostic Market: TAM, SAM, and SOM Analysis

  • 5.1 Total Addressable Market (TAM) Analysis, 2021 to 2033 (USD Billion)
  • 5.2 Serviceable Addressable Market (SAM) Analysis, 2021 to 2033 (USD Billion)
  • 5.3 Serviceable Obtainable Market (SOM) Analysis, 2021 to 2033 (USD Billion)

Chapter 6 U.S. Fertility Diagnostic Market: Procedure Type Estimates & Trend Analysis

  • 6.1 U.S. Fertility Diagnostic Market: Procedure Type Segment Dashboard
  • 6.2 Procedure Type Movement & Market Share Analysis, 2025 & 2033
  • 6.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Procedure Type, 2021 - 2033 (USD Million)
    • 6.3.1 X-Ray-Based Tubal Patency Testing
      • 6.3.1.1 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
      • 6.3.1.2 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
    • 6.3.2 Ultrasound-Based Tubal Patency Testing
      • 6.3.2.1 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
      • 6.3.2.2 Ultrasound-based tubal Patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
      • 6.3.2.3 HyCoSy (hysterosalpingo-contrast sonography)
        • 6.3.2.3.1 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
        • 6.3.2.3.2 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual Procedure Type Estimates in Thousands)
      • 6.3.2.4 HyFoSy (hysterosalpingo-foam sonography)
        • 6.3.2.4.1 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
        • 6.3.2.4.2 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
      • 6.3.2.5 Others
        • 6.3.2.5.1 Others market, 2021 - 2033 (USD Million)
        • 6.3.2.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
    • 6.3.3 Proprietary Controlled Contrast Systems
      • 6.3.3.1 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
      • 6.3.3.2 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
    • 6.3.4 Structural & Morphologic Imaging
      • 6.3.4.1 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
      • 6.3.4.2 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousands)
    • 6.3.5 Others
      • 6.3.5.1 Others market, 2021 - 2033 (USD Million)
      • 6.3.5.2 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)

Chapter 7 U.S. Fertility Diagnostic Market: Technology Type Estimates & Trend Analysis

  • 7.1 U.S. Fertility Diagnostic Market: Technology Type Segment Dashboard
  • 7.2 Technology Type Movement & Market Share Analysis, 2025 & 2033
  • 7.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Technology Type, 2021 - 2033 (USD Million)
    • 7.3.1 X-Ray-Based Technologies
      • 7.3.1.1 X-ray-based technologies market, 2021 - 2033 (USD Million)
    • 7.3.2 Ultrasound-Based Technologies
      • 7.3.2.1 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
    • 7.3.3 Proprietary Diagnostic Devices
      • 7.3.3.1 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)

Chapter 8 U.S. Fertility Diagnostic Market: Clinical Setting Estimates & Trend Analysis

  • 8.1 U.S. Fertility Diagnostic Market: Clinical Setting Segment Dashboard
  • 8.2 Clinical Setting Movement & Market Share Analysis, 2025 & 2033
  • 8.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, By Clinical Setting, 2021 - 2033 (USD Million)
    • 8.3.1 Fertility & Reproductive Medicine Clinics
      • 8.3.1.1 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
    • 8.3.2 Gynecology / Women's Health Practices
      • 8.3.2.1 Gynecology / women's health practices market, 2021 - 2033 (USD Million)
    • 8.3.3 Radiology & Imaging Centers
      • 8.3.3.1 Radiology & imaging centers market, 2021 - 2033 (USD Million)
    • 8.3.4 Hospital Outpatient Departments
      • 8.3.4.1 Hospital outpatient departments market, 2021 - 2033 (USD Million)
    • 8.3.5 others
      • 8.3.5.1 Others market, 2021 - 2033 (USD Million)

Chapter 9. U.S. Fertility Diagnostic Market: Region Estimates & Trend Analysis

  • 9.1 U.S. Fertility diagnostic Market: Region Movement Analysis
  • 9.2. U.S. Fertility Diagnostic Market: Region Segment Dashboard
  • 9.3. Region Movement & Market Share Analysis, 2025 & 2033
  • 9.4. U.S. Fertility Diagnostic Market Estimates & Forecast, by Region
  • 9.5. West
    • 9.5.1. West Market, 2021 - 2033 (USD Million)
  • 9.6. Southeast
    • 9.6.1. Southeast Market, 2021 - 2033 (USD Million)
  • 9.7. Southwest
    • 9.7.1. Southwest Market, 2021 - 2033 (USD Million)
  • 9.8. Midwest
    • 9.8.1. Midwest Market, 2021 - 2033 (USD Million)
  • 9.9. Northeast
    • 9.9.1. Northeast Market, 2021 - 2033 (USD Million)

Chapter 10 U.S. Fertility Diagnostic Market Competitive Landscape

  • 10.1 Participants' Overview
  • 10.2 Financial Performance
  • 10.3 Product Benchmarking
    • 10.3.1 Gedeon Richter
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3 Product Benchmarking
        • 10.3.1.3.1 Sonography
    • 10.3.2 Femvue (Femasys Inc.)
      • 10.3.2.1. Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3 Product Benchmarking
        • 10.3.2.3.1 Tube testing
    • 10.3.3 Thomas Medical (MedGyn)
      • 10.3.3.1. Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3 Product Benchmarking
        • 10.3.3.3.1 Infertility care
    • 10.3.4 Koninklijke Philips N.V.
      • 10.3.4.1. Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3 Product Benchmarking
        • 10.3.4.3.1 Gynecology ultrasound
    • 10.3.5 Ge Healthcare
      • 10.3.5.1. Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3 Product Benchmarking
        • 10.3.5.3.1 Ultrasound
    • 10.3.6 Samsung Healthcare
      • 10.3.6.1. Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3 Product Benchmarking
        • 10.3.6.3.1 Reproductive endocrinology and infertility
    • 10.3.7 Cooper Surgical, Inc.
      • 10.3.7.1. Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3 Product Benchmarking
        • 10.3.7.3.1. Andrology testing
        • 10.3.7.3.2 Embryo assessment diagnostics
        • 10.3.7.3.3 Hormone & biochemical fertility testing
        • 10.3.7.3.4 Milex support pessaries
    • 10.3.8 Mindray Ds Usa, Inc.
      • 10.3.8.1. Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3 Product Benchmarking
        • 10.3.8.3.1 Ultrasound solutions
        • 10.3.8.3.2 In vitro diagnostics
    • 10.3.9 Vio Healthtech Inc
      • 10.3.9.1 OvuSense tracker
      • 10.3.9.1. Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3 Product Benchmarking
        • 10.3.9.3.1 Ovusensor tracker.
    • 10.3.10 Fujifilm Sonosite, Inc.
      • 10.3.10.1. Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3 Product Benchmarking
        • 10.3.10.3.1 Portable ultrasound machines
    • 10.3.11 Olympus
      • 10.3.11.1. Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3 Product Benchmarking
        • 10.3.11.3.1 Microscopes & others
    • 10.3.12 Canon Medical Systems
      • 10.3.12.1. Overview
      • 10.3.12.2. Financial Performance
      • 10.3.12.3 Product Benchmarking
        • 10.3.12.3.1 Ultrasound
    • 10.3.13 Stryker
      • 10.3.13.1. Overview
      • 10.3.13.2. Financial Performance
      • 10.3.13.3 Product Benchmarking
      • 10.3.13.4 Imaging systems
  • 10.4 Participant Categorization
  • 10.5 Company Market Position Analysis, 2025
  • 10.6 Company Market Share Analysis, by Procedure Type, 2025
  • 10.7 Strategy Mapping
    • 10.7.1 New Product Launch
    • 10.7.2 Mergers & Acquisitions
    • 10.7.3 Partnership & Collaboration
    • 10.7.4 Market Expansion
    • 10.7.5 Product Approvals

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Percentage of first births, by age of mother: U.S., 2018 - 2023
  • Table 4 Annual incidence rates of female infertility diagnoses by age group, active component service women, US armed forces, 2019 - 2023
  • Table 5 Common tests for evaluating ovarian reserve and associated costs:
  • Table 6 Cost comparison - HyFoSy vs HSG
  • Table 7 Notable fertility diagnostic products available in or relevant to the US market
  • Table 8 U.S. infertility market, 2021 - 2033 (USD Billion) Total addressable market (TAM) analysis, 2021 to 2033 (USD Billion)
  • Table 9 Serviceable addressable market (SAM) analysis, 2021 to 2033 (USD Billion)
  • Table 10 Serviceable obtainable market (SOM) analysis, 2021 to 2033 (USD Billion)
  • Table 11 U.S. fertility diagnostic market, by procedure type 2021 - 2033 (USD Million)
  • Table 12 U.S. fertility diagnostic market, by technology type, 2021 - 2033 (USD Million)
  • Table 13 U.S. fertility diagnostic market, by clinical setting, 2021 - 2033 (USD Million)
  • Table 14 U.S. fertility diagnostic market revenue estimates and forecast, by region, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. fertility diagnostic market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. fertility diagnostic market snapshot
  • Fig. 9 U.S. fertility diagnostic market: Procedure type, and technology type snapshot
  • Fig. 10 U.S. fertility diagnostic market: Clinical setting snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 U.S. fertility diagnostic market dynamics
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 U.S. fertility diagnostic market: Porter's five forces analysis
  • Fig. 16 U.S. fertility diagnostic market: PESTLE analysis
  • Fig. 17 Prevalence/incidence of infertility in the US, by gender, 2025 %
  • Fig. 18 U.S. fertility diagnostic market: Procedure Type segment dashboard
  • Fig. 19 U.S. fertility diagnostic market: Procedure Type market share analysis, 2025 & 2033
  • Fig. 20 X-ray-based tubal patency testing market, 2021 - 2033 (USD Million)
  • Fig. 21 X-ray-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 22 Ultrasound-based tubal patency testing market, 2021 - 2033 (USD Million)
  • Fig. 23 Ultrasound-based tubal patency testing market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 24 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (USD Million)
  • Fig. 25 HyCoSy (hysterosalpingo-contrast sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 26 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (USD Million)
  • Fig. 27 HyFoSy (hysterosalpingo-foam sonography) market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 28 Other markets, 2021 - 2033 (USD Million)
  • Fig. 29 Other markets, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 30 Proprietary controlled contrast systems market, 2021 - 2033 (USD Million)
  • Fig. 31 Proprietary controlled contrast systems market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 32 Structural & morphologic imaging market, 2021 - 2033 (USD Million)
  • Fig. 33 Structural & morphologic imaging market, 2021 - 2033 (Annual procedure type estimates in thousand)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Others market, 2021 - 2033 (Annual procedure type estimates in thousands)
  • Fig. 36 U.S. fertility diagnostic market: Technology type segment dashboard
  • Fig. 37 U.S. fertility diagnostic market: Technology type market share analysis, 2025 & 2033
  • Fig. 38 X-ray-based technologies market, 2021 - 2033 (USD Million)
  • Fig. 39 Ultrasound-based technologies market, 2021 - 2033 (USD Million)
  • Fig. 40 Proprietary diagnostic devices market, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. fertility diagnostic market: Clinical setting segment dashboard
  • Fig. 42 U.S. fertility diagnostic market: Clinical setting market share analysis, 2025 & 2033
  • Fig. 43 Fertility & reproductive medicine clinics market, 2021 - 2033 (USD Million)
  • Fig. 44 Gynecology / women's health practices market, 2021 - 2033 (USD Million)
  • Fig. 45 Radiology & imaging centers market, 2021 - 2033 (USD Million)
  • Fig. 46 Hospital outpatient departments market, 2021 - 2033 (USD Million)
  • Fig. 47 Others market, 2021 - 2033 (USD Million)
  • Fig. 48 USfertility diagnostic market: Region movement analysis
  • Fig. 49 U.S. fertility diagnostic market: Region segment dashboard
  • Fig. 50 Northeast market, 2021 - 2033 (USD Million)
  • Fig. 51 Southeast market, 2021 - 2033 (USD Million)
  • Fig. 52 Southwest market, 2021 - 2033 (USD Million)
  • Fig. 53 Midwest market, 2021 - 2033 (USD Million)
  • Fig. 54 West market, 2021 - 2033 (USD Million)
  • Fig. 55 Company categorization
  • Fig. 56 Company market position analysis, 2025
  • Fig. 57 Strategy mapping